Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
复制标题
鸟分枝杆菌复合群肺病患者的血清氧化应激
DOI:
10.1016/j.heliyon.2019.e02775
复制
发表时间:
2019
期刊:
影响因子:
4
通讯作者:
Tatsuno Ichiro
中科院分区:
文献类型:
--
作者:
Wakabayashi Hiroki;Matsuzawa Yasuo;Hayakawa Sho;Irie Tamako;Rikitake Hagino;Tatsuno Ichiro
BackgroundThe mechanism of progressive airway destruction in incurable chronic infection of the lung – termed pulmonaryMycobacterium aviumcomplex (pMAC) disease – is currently unknown. The involvement of oxidative stress in a variety of progressive chronic respiratory diseases has been previously reported. It has been hypothesized that oxidative stress may be involved in the progression of airway destruction in pMAC disease.Patients and methodsThe study included 28 untreated patients with pMAC disease. The level of serum oxidative stress was quantitatively evaluated through the diacron reactive oxygen metabolites (d-ROMs) test, which indirectly measures the level of hydroperoxide in the serum. In addition, patients were divided into three groups based on the severity shown in the computed tomographic image.ResultsThe level of serum oxidative stress exceeded the normal range (250–300 U.Carr [Carratelli Units]) in all patients with pMAC disease (mean: 495.5 ± 102.6 U.Carr; minimum–maximum: 340–734 U.Carr). The level of serum oxidative stress in patients with severe disease was significantly higher compared with that observed in patients with mild disease (434.6 ± 30.2 vs. 583.4 ± 95.1, respectively, p=0.009).ConclusionsIn patients with pMAC disease, an elevation was observed in the level of serum oxidative stress. This increase in oxidative stress was more pronounced in patients with severe disease.